{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Health Affairs This Week","title":"FDA Comes Under Scrutiny","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/1d202901\"></iframe>","width":"100%","height":180,"duration":901,"description":"Health Affairs' Michael Gerber and Rob Lott discuss the latest developments at the FDA, including the first oral treatment for postpartum depression, the Accelerated Approval Program, and the agency being namechecked on the GOP presidential campaign trail.\nRelated Links:\nCreate An Economic Incentive For The Timely Completion Of Confirmatory Trials (Health Affairs Forefront)\nThe Conundrum Of Patient Access To Therapeutic Medical Devices (Health Affairs Forefront)\nFDA Approves First Oral Treatment for Postpartum Depression \nRequest For Abstracts - Reimagining Public Health\nRequest For Abstracts - Perinatal Mental Health\nCurrently, more than 70 percent of our content is freely available — and we’d like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.","thumbnail_url":"https://img.transistorcdn.com/1yTEmrg3NcfwPvygDcOosqdCKJnotdzHk5P0Oq8y-us/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE2NjA3LzE2MDY4/MzkyNjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}